Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 34.01 CNY -1.13% Market Closed
Market Cap: 26.2B CNY
Have any thoughts about
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock under the Base Case scenario is 42.93 CNY. Compared to the current market price of 34.01 CNY, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
42.93 CNY
Undervaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Provide an overview of the primary business activities
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

What unique competitive advantages
does Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd hold over its rivals?

What risks and challenges
does Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide P/S
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide P/E
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide P/OCF
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide P/FCFE
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide P/B
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/S
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/GP
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/EBITDA
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/EBIT
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/OCF
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/FCFF
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide EV/IC
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Show me price targets
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd made by professional analysts.

What are the Revenue projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

How accurate were the past Revenue estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

What are the Net Income projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

How accurate were the past Net Income estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

What are the EPS projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

How accurate were the past EPS estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

What are the EBIT projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

How accurate were the past EBIT estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

Compare the revenue forecasts
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd compared to its peers.

Compare the P/E ratios
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd with its peers.

Analyze the financial leverage
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd compared to its main competitors.

Show all profitability ratios
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide ROE
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide ROA
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide ROIC
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide ROCE
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Gross Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Operating Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Net Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide FCF Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Show all solvency ratios
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide D/E Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide D/A Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Interest Coverage Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Altman Z-Score Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Quick Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Current Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Provide Cash Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

What is the historical Revenue growth
over the last 5 years for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

What is the historical Net Income growth
over the last 5 years for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

What is the current Free Cash Flow
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Current Assets 8.2B
Cash & Short-Term Investments 3.4B
Receivables 3B
Other Current Assets 1.8B
Non-Current Assets 3.7B
Long-Term Investments 1.6B
PP&E 1.5B
Intangibles 388.1m
Other Non-Current Assets 324.2m
Current Liabilities 5.2B
Accounts Payable 702.2m
Accrued Liabilities 437m
Short-Term Debt 1.2B
Other Current Liabilities 2.9B
Non-Current Liabilities 378.3m
Long-Term Debt 234.3m
Other Non-Current Liabilities 144m
Efficiency

Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Revenue
8.1B CNY
Cost of Revenue
-4.5B CNY
Gross Profit
3.6B CNY
Operating Expenses
-2.8B CNY
Operating Income
793.9m CNY
Other Expenses
128.1m CNY
Net Income
921.9m CNY

Free Cash Flow Analysis
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Negative Net Debt
Long-Term Solvency
69/100
Solvency
Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Wall Street analysts forecast Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

Lowest
Price Target
46.26 CNY
36% Upside
Average
Price Target
46.72 CNY
37% Upside
Highest
Price Target
48.09 CNY
41% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

26.2B CNY

Dividend Yield

0%

Description

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. engages in the research, development, processing, wholesale, retail, and manufacturing of Chinese herbal medicines, Chinese patent medicines, Chinese medicine decoction tablets, western medicine preparations, and other medical and health products. The company is headquartered in Tianjin, Tianjin and currently employs 4,650 full-time employees. The company went IPO on 2001-06-06. The firm's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The firm's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Contact

TIANJIN
Tianjin
No. 17, Baidi Road, Nankai District
+862227020892
www.zhongxinp.com

IPO

2001-06-06

Employees

4 650

Officers

GM & Executive Director
Ms. Lei Wang
Chief Financial Officer
Mr. Jian Ma
Deputy GM, Chief Engineer & Executive Director
Mr. Hong Zhou
Chief Manufacturing Officer
Mr. Yu Zhang
Executive Director
Mr. Mingjie Shang
Secretary to the Board of Directors
Ms. Yan Jiao

See Also

Discover More
What is the Intrinsic Value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock?

The intrinsic value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock under the Base Case scenario is 42.93 CNY.

Is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock undervalued or overvalued?

Compared to the current market price of 34.01 CNY, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is Undervalued by 21%.

Back to Top